Loo S, Roberts AW, Anstee NS, Kennedy GA, et al. Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLG. Blood 2023;142:1960-1971.
PMID: 37647654